# Codex Review: medical_monitoring_assurance_backend_completion_gate_20260803

Date: 2026-08-03 CST
Delegated-agent output: `runs/codex_medical_monitoring_assurance_backend_completion_gate_20260803.md`

## Verdict

PASS — high-risk backend completion gate correction; Hermes workflow review-gate is
required and will be run after this final evidence update.

This is not an approval of any real clinical project or commercial release.

## Boundary Check

- Codex performed the work directly inside the workbench; no delegated external agent
  was dispatched.
- Only the assurance service and its existing assurance test were changed. Temporary
  SQLite mutation is confined to a pytest `tmp_path`; no authority/runtime database,
  B6/C14 artifact, provider, browser, service, real project or medical-writing surface
  was touched.

## Codex Verification

- P8 §12 source gate requires three-level agreement and verifiable closure/explanation
  evidence.
- `validate_pre_inspection_rollup` now validates task/project/snapshot identity, strict
  non-negative counts, duplicate-free trial/site/subject ID sets, exact cross-level
  conservation, complete evidence/remediation manifests and explicit zero closed-risk
  evidence gaps before `repository.complete_task`.
- Focused `tests/test_monitoring_assurance.py`: **27 passed**, including a persisted
  site-identity tamper that returns 409 before completion.
- Shared assurance/frontend/Timeline contract set: **84 passed**.
- Full `tests/test_monitoring*.py`: **1783 passed** in **492.68s**, 25 existing warnings;
  no test failure. Ruff and compile checks passed.
- No listener on 8911/5174; B6/C14 state unchanged.

## Delegated-Agent Output Review

- The validator is deterministic and ID/reference-only; it does not copy or infer
  clinical facts and does not alter rollup generation semantics.
- The test mutates only a temporary DB row after a valid generated rollup and medical
  review, demonstrating the backend boundary rather than relying on frontend state.
- No unsupported completion or release claim is made. Existing backend warnings are
  preserved as residuals.

## Residual Risk

- Real three-project evidence, browser/scientific/UAT, formal B6 reviewer outcomes,
  aggregate/CAS expected versions, MY009 source-token provenance, identity/RBAC,
  restart/performance/audit and commercial release remain unverified or blocked.
- The validator currently reports deterministic blocker codes in the 409 message; a
  future user-facing action panel may map these codes to localized remediation guidance.
